Close

Articles Posted in High Alert Drugs

Updated:

The Importance of Adequate Warnings on Prescription Medications in Maryland

Manufacturers of pharmaceutical drugs – like other products – are responsible for the products they market and release to the public. Some drugs pose a serious health risk due to potential negative interactions with other commonly taken medications, other medications are easily abused and can lead to dependence or addiction,…

Updated:

Recent Study Indicates that Type 1 Diabetes Patients Are at Especially High Risk of Experiencing a Medication Error

In the pharmacy world, it is well-known that diabetic patients are among those with the highest risk of being victims of Maryland medication errors. This is due mostly to the fact that diabetic patients are often required to take several medications in a very specific dose, as well as the…

Updated:

Pharmacy Errors Involving High-Alert Medications

While all prescription drugs pose risks if taken in large quantities or by certain patients taking other medications, some medications have such a high likelihood of being involved in a Maryland pharmacy error that they have been labeled as “high-alert” medications. According to a recent industry news report, high-alert medications…

Updated:

New Insulin Use Guidelines Aim to Reduce Risk of Insulin Prescription Errors

Patients have to put a great deal of faith in their doctors, nurses, and pharmacists. We put our lives in the hands of medical providers. But medical providers can make mistakes just like anyone else. Since medication errors occur all too frequently, doctors, nurses, and pharmacists have to be vigilant…

Updated:

Court Prevents Plaintiff’s Expert from Testifying in Case Against Drug Manufacturer

Earlier this month, a federal appellate court issued a written opinion in a product liability case brought against the manufacturer of Zoloft, alleging that the medication causes birth defects. The court’s decision reviewed a lower court’s decision to prevent the plaintiffs’ expert witness from testifying. Ultimately, the court concluded that…

Updated:

Court Concludes Patient’s Own Actions Constitute Intervening Cause in Prescription Medicine Overdose Case

Earlier last month, an appellate court in Tennessee issued a written opinion in a case involving the death of a man who had overdosed on prescription medication. The court ultimately determined that the patient’s death was attributable to his own actions. The case was presented to the court as a…

Updated:

Most Common Pharmacy Error of 2016 Was a Pharmacist’s Dispensing of the Incorrect Drug

The Institute for Safe Medication Practices (ISMP) has released a report that discusses the most common pharmacy errors of 2016 and strategies to prevent these errors from harming patients in the future. The ISMP is an industry trade association containing pharmaceutical companies, doctors, pharmacists, and other medical professionals that regularly conducts observations…

Updated:

High-Alert Drugs Pose a Heightened Risk to Patients, Yet Many Hospitals Fail to Identify Them

The Institute for Safe Medication Practices (ISMP) creates an evolving list of high-alert medications that, while they are not necessarily more likely to be involved in an error, are especially dangerous if they are accidentally given to a patient. However, according to one industry news report, despite the availability of this…

Updated:

Court Holds Insurance Company Must Defend Lawsuit Against Medication Distributor

Prescription drugs are controlled by the government for a reason. Often, prescription drugs are dangerous if they are taken in conjunction with other medications, can more easily lead to an inadvertent overdose, and may easily lead to abuse because of their addictive qualities. Over the past few years, the court…

Contact Us